HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
- 1 January 1998
- journal article
- letter
- Published by Springer Nature in Nature
- Vol. 391 (6665) , 397-401
- https://doi.org/10.1038/34929
Abstract
Cytotoxic T lymphocytes (CTLs) lyse virally infected cells that display viral peptide epitopes in association with major histocompatibility complex (MHC) class I molecules on the cell surface. However, despite a strong CTL response directed against viral epitopes, untreated people infected with the human immunodeficiency virus (HIV-1) develop AIDS. To resolve this enigma, we have examined the ability of CTLs to recognize and kill infected primary T lymphocytes. We found that CTLs inefficiently lysed primary cells infected with HIV-1 if the viral nef gene product was expressed. Resistance of infected cells to CTL killing correlated with nef-mediated downregulation of MHC class I (ref. 1) and could be overcome by adding an excess of the relevant HIV-1 epitope as soluble peptide. Thus, Nef protected infected cells by reducing the epitope density on their surface. This effect of nef may allow evasion of CTL lysis by HIV-1-infected cells.Keywords
This publication has 30 references indexed in Scilit:
- The Human Immunodeficiency Virus Type 1 (HIV-1) Vpu Protein Interferes with an Early Step in the Biosynthesis of Major Histocompatibility Complex (MHC) Class I MoleculesThe Journal of Experimental Medicine, 1997
- Stimulation of human cytotoxic T cells with HIV-1-derived peptides presented by recombinant HLA-A2 peptide complexesInternational Immunology, 1997
- MHC Class I–Restricted CTL Responses to Exogenous AntigensImmunity, 1996
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.The Journal of Experimental Medicine, 1995
- Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1.The Journal of Experimental Medicine, 1994
- Repression of MHC Class I Gene Promoter Activity by Two-Exon Tat of HIVScience, 1993
- Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognitionNature, 1991
- Downregulation of HLA Class I Antigens in HIV-1-Infected CellsAIDS Research and Human Retroviruses, 1989
- Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNANature, 1988